Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Biffoni

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Scientific Reports|February 10, 2016
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical OutcomeG Marziali, M Signore, M Buccarelli, et al.
Radiation Protection Dosimetry|May 14, 2015
Glioblastoma stem cells: radiobiological response to ionising radiations of different qualitiesI Pecchia, V Dini, L Ricci-Vitiani, et al.
Cell Death & Disease|May 10, 2014
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoM Signore, F Pelacchi, S di Martino, et al.
Oncogene|May 23, 2012
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transitionV Coppola, M Musumeci, M Patrizii, et al.
Cell Death and Differentiation|November 26, 2011
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapyM Bartucci, S Svensson, P Romania, et al.
Oncogene|May 3, 2011
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancerM Musumeci, V Coppola, A Addario, et al.
Oncogene|February 18, 2014
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cellsM Bartucci, R Dattilo, C Moriconi, et al.
Updates in Surgery|April 1, 2025
Intraoperative nerve monitoring in thyroid and parathyroid surgery: a decade of Italian practiceR Melcarne, G Docimo, P S L Aiello, et al.
NPJ Precision Oncology|April 10, 2026
The role of the molecular tumor board: learnings from the ROME trialP Marchetti, G Curigliano, C B Westphalen, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Scientific Reports|February 10, 2016
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical OutcomeG Marziali, M Signore, M Buccarelli, et al.
Radiation Protection Dosimetry|May 14, 2015
Glioblastoma stem cells: radiobiological response to ionising radiations of different qualitiesI Pecchia, V Dini, L Ricci-Vitiani, et al.
Cell Death & Disease|May 10, 2014
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoM Signore, F Pelacchi, S di Martino, et al.
Oncogene|May 23, 2012
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transitionV Coppola, M Musumeci, M Patrizii, et al.
Cell Death and Differentiation|November 26, 2011
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapyM Bartucci, S Svensson, P Romania, et al.
Oncogene|May 3, 2011
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancerM Musumeci, V Coppola, A Addario, et al.
Oncogene|February 18, 2014
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cellsM Bartucci, R Dattilo, C Moriconi, et al.
Updates in Surgery|April 1, 2025
Intraoperative nerve monitoring in thyroid and parathyroid surgery: a decade of Italian practiceR Melcarne, G Docimo, P S L Aiello, et al.
NPJ Precision Oncology|April 10, 2026
The role of the molecular tumor board: learnings from the ROME trialP Marchetti, G Curigliano, C B Westphalen, et al.
Pageof 6